| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 999.546.042 $ | 99,89 | 19.620.026 | |||||||
| JOHNSON & JOHNSON | JOHNSON JOHNSON | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 230.416.966 $ | 23,03 | 942.632 | |
| ELI LILLY AND COMPANY | ELI LILLY CO | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 210.707.350 $ | 21,06 | 229.087 | |
| MERCK & CO., INC. | MERCK CO INC | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 47.418.318 $ | 4,74 | 394.200 | |
| PFIZER INC. | PFIZER INC | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 47.118.858 $ | 4,71 | 1.678.022 | |
| ROYALTY PHARMA PLC | ROYALTY PHARMA PLC | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 47.065.861 $ | 4,70 | 981.152 | |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL MYERS SQUIBB CO | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 46.321.680 $ | 4,63 | 763.754 | |
| ZOETIS INC. | ZOETIS INC | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 45.205.750 $ | 4,52 | 382.419 | |
| VIATRIS INC. | VIATRIS INC | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 43.491.311 $ | 4,35 | 3.219.194 | |
| ELANCO ANIMAL HEALTH INCORPORATED | ELANCO ANIMAL HEALTH INC | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 33.232.333 $ | 3,32 | 1.388.731 | |
| JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | JAZZ PHARMACEUTICALS PLC | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 32.107.874 $ | 3,21 | 169.838 | |
| AXSOME THERAPEUTICS, INC. | AXSOME THERAPEUTICS INC | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 20.005.038 $ | 2,00 | 118.359 | |
| Terns Pharmaceuticals Inc | TERNS PHARMACEUTICALS INC | EC | 880881107 | Long | Börsenkurs (Stufe 1) | 12.675.417 $ | 1,27 | 240.429 | |
| LIGAND PHARMACEUTICALS INCORPORATED | LIGAND PHARMACEUTICALS | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 10.982.946 $ | 1,10 | 55.011 | |
| INDIVIOR PHARMACEUTICALS, INC. | INDIVIOR PHARMACEUTICALS INC | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 10.636.514 $ | 1,06 | 348.967 | |
| CORCEPT THERAPEUTICS INCORPORATED | CORCEPT THERAPEUTICS INC | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 10.547.515 $ | 1,05 | 261.660 | |
| Crinetics Pharmaceuticals Inc | CRINETICS PHARMACEUTICALS INC | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 10.406.406 $ | 1,04 | 286.520 | |
| SUPERNUS PHARMACEUTICALS, INC. | SUPERNUS PHARMACEUTICALS INC | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 8.283.994 $ | 0,83 | 160.263 | |
| PRESTIGE CONSUMER HEALTHCARE INC. | PRESTIGE CONSUMER HEALTH | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 7.838.872 $ | 0,78 | 132.257 | |
| Tarsus Pharmaceuticals Inc | TARSUS PHARMACEUTICALS INC | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 7.657.153 $ | 0,77 | 109.154 | |
| Liquidia Corp | LIQUIDIA CORP | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 7.249.477 $ | 0,72 | 192.090 | |
| Edgewise Therapeutics Inc | EDGEWISE THERAPEUTICS INC | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 6.524.627 $ | 0,65 | 207.131 | |
| AMNEAL PHARMACEUTICALS, INC. | AMNEAL PHARMACEUTICALS INC | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 5.897.637 $ | 0,59 | 474.468 | |
| NEKTAR THERAPEUTICS | NEKTAR THERAPEUTICS | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 5.626.778 $ | 0,56 | 78.204 | |
| Definium Therapeutics Inc | DEFINIUM THERAPEUTICS INC | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 5.203.775 $ | 0,52 | 275.332 | |
| Alumis Inc | ALUMIS INC | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 4.990.919 $ | 0,50 | 226.551 | |
| Enliven Therapeutics Inc | ENLIVEN THERAPEUTICS INC | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 4.876.715 $ | 0,49 | 124.406 | |
| INNOVIVA, INC. | INNOVIVA INC | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 4.625.749 $ | 0,46 | 198.530 | |
| ORGANON & CO. | ORGANON CO | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 4.352.645 $ | 0,43 | 726.652 | |
| PERRIGO COMPANY PUBLIC LIMITED COMPANY | PERRIGO CO PLC | EC | G97822103 | Long | Börsenkurs (Stufe 1) | 4.131.238 $ | 0,41 | 384.659 | |
| OCULAR THERAPEUTIX, INC. | OCULAR THERAPEUTIX INC | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 4.122.849 $ | 0,41 | 486.759 | |
| ANI PHARMACEUTICALS, INC. | ANI PHARMACEUTICALS INC | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 3.863.994 $ | 0,39 | 50.247 | |
| Trevi Therapeutics Inc | TREVI THERAPEUTICS INC | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 3.463.351 $ | 0,35 | 290.306 | |
| HARROW, INC. | HARROW INC | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 3.248.539 $ | 0,32 | 92.131 | |
| Amylyx Pharmaceuticals Inc | AMYLYX PHARMACEUTICALS INC | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 3.242.592 $ | 0,32 | 233.280 | |
| PHIBRO ANIMAL HEALTH CORPORATION | PHIBRO ANIMAL HEALTH CORP | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 3.188.290 $ | 0,32 | 57.644 | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | HARMONY BIOSCIENCES HOLDINGS INC | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 3.111.267 $ | 0,31 | 111.077 | |
| WAVE Life Sciences Ltd | WAVE LIFE SCIENCES LTD | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 2.929.479 $ | 0,29 | 404.066 | |
| Collegium Pharmaceutical, Inc. | COLLEGIUM PHARMACEUTICAL INC | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 2.921.801 $ | 0,29 | 88.352 | |
| Nuvation Bio Inc | NUVATION BIO INC | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 2.869.131 $ | 0,29 | 668.795 | |
| EYEPOINT, INC. | EYEPOINT INC | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 2.803.652 $ | 0,28 | 217.506 | |
| XERIS BIOPHARMA HOLDINGS, INC. | XERIS BIOPHARMA HOLDINGS INC | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 2.689.796 $ | 0,27 | 463.758 | |
| PACIRA BIOSCIENCES, INC. | PACIRA BIOSCIENCES INC | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 2.592.672 $ | 0,26 | 114.720 | |
| Rapport Therapeutics Inc | RAPPORT THERAPEUTICS INC | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 2.500.916 $ | 0,25 | 79.927 | |
| MBX Biosciences Inc | MBX BIOSCIENCES INC | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 2.097.858 $ | 0,21 | 70.280 | |
| OMEROS CORPORATION | OMEROS CORP | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 2.092.622 $ | 0,21 | 198.165 | |
| AMPHASTAR PHARMACEUTICALS, INC. | AMPHASTAR PHARMACEUTICALS INC | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 1.937.353 $ | 0,19 | 98.895 | |
| Arvinas Inc | ARVINAS INC | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 1.902.764 $ | 0,19 | 179.506 | |
| Maze Therapeutics Inc | MAZE THERAPEUTICS INC | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 1.766.433 $ | 0,18 | 59.177 | |
| THERAVANCE BIOPHARMA, INC. | THERAVANCE BIOPHARMA INC | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 1.678.003 $ | 0,17 | 103.389 | |
| LB Pharmaceuticals Inc | LB PHARMACEUTICALS INC | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 1.675.894 $ | 0,17 | 67.960 | |
| PHATHOM PHARMACEUTICALS, INC. | PHATHOM PHARMACEUTICALS INC | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 1.548.501 $ | 0,15 | 139.379 | |
| Septerna Inc | SEPTERNA INC | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 1.533.667 $ | 0,15 | 63.823 | |
| BIOAGE Labs Inc | BIOAGE LABS INC | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 1.469.545 $ | 0,15 | 84.022 | |
| CORMEDIX INC. | CORMEDIX INC | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 1.390.592 $ | 0,14 | 204.800 | |
| Evolus Inc | EVOLUS INC | EC | 30052C107 | Long | Börsenkurs (Stufe 1) | 744.613 $ | 0,07 | 181.171 | |
| LENZ Therapeutics Inc | LENZ THERAPEUTICS INC | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 560.154 $ | 0,06 | 61.219 | |
| 999.546.042 $ | 99,89 | 19.620.026 |